Cargando…

MON-504 Osteomalacia During Pregnancy: Are Preventive Measures Enough to Avoid Future Fractures and Fetal Complications?

Title Osteomalacia during pregnancy; are preventive measures enough to prevent future fractures and fetal complications? Background We present a patient with a left hip fracture found to have FGF-23 induced osteomalacia whose clinical course was complicated by pregnancy. Clinical Case A 28 year old...

Descripción completa

Detalles Bibliográficos
Autores principales: Pujals Kury, Jean, Soni, Lina, Sattar, Moin, Yau, Alice, Luis Lam, Milay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6551182/
http://dx.doi.org/10.1210/js.2019-MON-504
_version_ 1783424353993490432
author Pujals Kury, Jean
Soni, Lina
Sattar, Moin
Yau, Alice
Luis Lam, Milay
author_facet Pujals Kury, Jean
Soni, Lina
Sattar, Moin
Yau, Alice
Luis Lam, Milay
author_sort Pujals Kury, Jean
collection PubMed
description Title Osteomalacia during pregnancy; are preventive measures enough to prevent future fractures and fetal complications? Background We present a patient with a left hip fracture found to have FGF-23 induced osteomalacia whose clinical course was complicated by pregnancy. Clinical Case A 28 year old female with a history of iron deficiency anemia presented with left hip pain resulting in difficulty ambulating. Nine months prior, she had suffered a fall at home where she slid down nine steps on her left side, she developed pain in her left leg that prompted her to seek care in multiple emergency rooms; she was given acetaminophen for pain only. Seven months after the fall she started limping requiring a cane to ambulate, a week before admission, she had another mechanical fall where she slipped and fell landing again on her left hip after which she sought care. Further history revealed no regular intake of any medication including no inhaled or systemic steroids, regular menses and no symptoms of hyperthyroidism or malabsorption. Physical exam was pertinent for limited range of motion of her left leg. Blood tests were significant for alkaline phosphatase (ALP) 220 [30-95U/L], phosphorus 2.1 [2.5-5.0mg/dL], 25-OH vitamin D 14.80 [30-95pg/mL], Vitamin D 1,25(OH)2 <8 [18-72pg/mL], and Fibroblast Growth Factor 23 (FGF-23) 1241 [<180RU/ML]. Other labs included: Calcium 9.3 [8.2-10mg/dL], albumin 4.28 [3.5-5.70 g/dL], PTH 37.9 [15.0-65.0pg/mL], ALP isoenzymes: total ALP 202 [33-115 U/L], liver 44 [25-69%], bone 56 [28-66%], 24hr urine phosphorus 0.5 [0.3-1.3g/24hr] with under collected specimen , volume 1 liter and creatinine 0.9 [1-2 g/24hr], TSH 2.54 [0.35-4.70 uI/mL], cortisol after 1mg Dexamethasone was 0.3 [<1.8 mcg/dL]. The grossly elevated FGF-23 lead to a suspicion of tumor-induced osteomalacia, Imaging revealed stress fractures of the left aspect of the sacrum and left femoral neck. A bone scan was significant for diffuse lesions and bone densitometry showed osteoporosis in the lumbar region with a Z score of-2.5 and osteopenia of lumbar and femoral neck Z -1.9. Femoral neck biopsy was negative for malignancy. She underwent percutaneous pining of the femoral neck and was discharged with calcitriol, cholecalciferol and phosphate supplementation. An Octreotide scan obtained during follow-up was negative. Her phosphate levels have been difficult to manage even with high supplementation of phosphate, and further attempts to localize the tumor have been temporarily held as the patient is now pregnant. Conclusion This patient who initially presented with femoral neck and sacrum stress fractures and diagnosed with osteomalacia and hypophosphatemia allows us to learn and question what the appropriate treatment strategy should be to ensure both patient and fetus are adequately supplemented to prevent any future fractures in the mother and promote normal development of the fetus.
format Online
Article
Text
id pubmed-6551182
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Endocrine Society
record_format MEDLINE/PubMed
spelling pubmed-65511822019-06-13 MON-504 Osteomalacia During Pregnancy: Are Preventive Measures Enough to Avoid Future Fractures and Fetal Complications? Pujals Kury, Jean Soni, Lina Sattar, Moin Yau, Alice Luis Lam, Milay J Endocr Soc Bone and Mineral Metabolism Title Osteomalacia during pregnancy; are preventive measures enough to prevent future fractures and fetal complications? Background We present a patient with a left hip fracture found to have FGF-23 induced osteomalacia whose clinical course was complicated by pregnancy. Clinical Case A 28 year old female with a history of iron deficiency anemia presented with left hip pain resulting in difficulty ambulating. Nine months prior, she had suffered a fall at home where she slid down nine steps on her left side, she developed pain in her left leg that prompted her to seek care in multiple emergency rooms; she was given acetaminophen for pain only. Seven months after the fall she started limping requiring a cane to ambulate, a week before admission, she had another mechanical fall where she slipped and fell landing again on her left hip after which she sought care. Further history revealed no regular intake of any medication including no inhaled or systemic steroids, regular menses and no symptoms of hyperthyroidism or malabsorption. Physical exam was pertinent for limited range of motion of her left leg. Blood tests were significant for alkaline phosphatase (ALP) 220 [30-95U/L], phosphorus 2.1 [2.5-5.0mg/dL], 25-OH vitamin D 14.80 [30-95pg/mL], Vitamin D 1,25(OH)2 <8 [18-72pg/mL], and Fibroblast Growth Factor 23 (FGF-23) 1241 [<180RU/ML]. Other labs included: Calcium 9.3 [8.2-10mg/dL], albumin 4.28 [3.5-5.70 g/dL], PTH 37.9 [15.0-65.0pg/mL], ALP isoenzymes: total ALP 202 [33-115 U/L], liver 44 [25-69%], bone 56 [28-66%], 24hr urine phosphorus 0.5 [0.3-1.3g/24hr] with under collected specimen , volume 1 liter and creatinine 0.9 [1-2 g/24hr], TSH 2.54 [0.35-4.70 uI/mL], cortisol after 1mg Dexamethasone was 0.3 [<1.8 mcg/dL]. The grossly elevated FGF-23 lead to a suspicion of tumor-induced osteomalacia, Imaging revealed stress fractures of the left aspect of the sacrum and left femoral neck. A bone scan was significant for diffuse lesions and bone densitometry showed osteoporosis in the lumbar region with a Z score of-2.5 and osteopenia of lumbar and femoral neck Z -1.9. Femoral neck biopsy was negative for malignancy. She underwent percutaneous pining of the femoral neck and was discharged with calcitriol, cholecalciferol and phosphate supplementation. An Octreotide scan obtained during follow-up was negative. Her phosphate levels have been difficult to manage even with high supplementation of phosphate, and further attempts to localize the tumor have been temporarily held as the patient is now pregnant. Conclusion This patient who initially presented with femoral neck and sacrum stress fractures and diagnosed with osteomalacia and hypophosphatemia allows us to learn and question what the appropriate treatment strategy should be to ensure both patient and fetus are adequately supplemented to prevent any future fractures in the mother and promote normal development of the fetus. Endocrine Society 2019-04-30 /pmc/articles/PMC6551182/ http://dx.doi.org/10.1210/js.2019-MON-504 Text en Copyright © 2019 Endocrine Society https://creativecommons.org/licenses/by-nc-nd/4.0/ This article has been published under the terms of the Creative Commons Attribution Non-Commercial, No-Derivatives License (CC BY-NC-ND; https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Bone and Mineral Metabolism
Pujals Kury, Jean
Soni, Lina
Sattar, Moin
Yau, Alice
Luis Lam, Milay
MON-504 Osteomalacia During Pregnancy: Are Preventive Measures Enough to Avoid Future Fractures and Fetal Complications?
title MON-504 Osteomalacia During Pregnancy: Are Preventive Measures Enough to Avoid Future Fractures and Fetal Complications?
title_full MON-504 Osteomalacia During Pregnancy: Are Preventive Measures Enough to Avoid Future Fractures and Fetal Complications?
title_fullStr MON-504 Osteomalacia During Pregnancy: Are Preventive Measures Enough to Avoid Future Fractures and Fetal Complications?
title_full_unstemmed MON-504 Osteomalacia During Pregnancy: Are Preventive Measures Enough to Avoid Future Fractures and Fetal Complications?
title_short MON-504 Osteomalacia During Pregnancy: Are Preventive Measures Enough to Avoid Future Fractures and Fetal Complications?
title_sort mon-504 osteomalacia during pregnancy: are preventive measures enough to avoid future fractures and fetal complications?
topic Bone and Mineral Metabolism
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6551182/
http://dx.doi.org/10.1210/js.2019-MON-504
work_keys_str_mv AT pujalskuryjean mon504osteomalaciaduringpregnancyarepreventivemeasuresenoughtoavoidfuturefracturesandfetalcomplications
AT sonilina mon504osteomalaciaduringpregnancyarepreventivemeasuresenoughtoavoidfuturefracturesandfetalcomplications
AT sattarmoin mon504osteomalaciaduringpregnancyarepreventivemeasuresenoughtoavoidfuturefracturesandfetalcomplications
AT yaualice mon504osteomalaciaduringpregnancyarepreventivemeasuresenoughtoavoidfuturefracturesandfetalcomplications
AT luislammilay mon504osteomalaciaduringpregnancyarepreventivemeasuresenoughtoavoidfuturefracturesandfetalcomplications